Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1,226,467,754
-
Total 13F shares
-
259,719,343
-
Share change
-
-4,278,659
-
Total reported value
-
$14,402,699,131
-
Put/Call ratio
-
90%
-
Price per share
-
$55.46
-
Number of holders
-
755
-
Value change
-
-$180,272,150
-
Number of buys
-
404
-
Number of sells
-
276
Institutional Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q1 2025
As of 31 Mar 2025,
Sanofi - Common Stock and American Depositary Receipts (SNY) was held by
755 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
259,719,343 shares.
The largest 10 holders included
Dodge & Cox, Fisher Asset Management, LLC, Invesco Ltd., PRICE T ROWE ASSOCIATES INC /MD/, BANK OF AMERICA CORP /DE/, Capital World Investors, MORGAN STANLEY, BARROW HANLEY MEWHINNEY & STRAUSS LLC, BlackRock, Inc., and FMR LLC.
This page lists
760
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.